A significant decrease of TRPM3 current amplitude was reported after modulation with ononetin in both ME/CFS patients taking LDN (p=0.0336) and HC (p=0.0205) groups. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.